Omnicell, Inc. (OMCL) Valuation — DCF & Advanced Analysis | MarketCI

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Navigation

Explore Analysis Investor Relations AI Assistant Compare Screener

Help Pricing Privacy Terms

Omnicell, Inc. (OMCL) Valuation — DCF & Advanced Analysis | MarketCI | MarketCI

OMCL

Market Closed

Omnicell, Inc.

NASDAQHealthcare Medical - Healthcare Information Services

3.62K employees

CEO: Randall A. Lipps

Founded: 2001

$39.90

+$0.00(+NaN%)

Market Cap

1.81B

Beta

0.96

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Comprehensive Valuation

In-depth valuation analysis including DCF scenarios and peer comparisons.

AI Insight: Omnicell's current price aligns closely with its fair value, indicating a fairly valued stock amid wide valuation ranges and high leverage risk. Monte Carlo analysis shows substantial volatility and a 75% downside risk below current price, signaling notable uncertainty. Strong growth contrasts with low profitability and efficiency, reflecting mixed fundamentals.

Enhanced Football Field Analysis

Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore OMCL

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples